Last reviewed · How we verify
Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
This is a multicenter, randomized, parallel controlled Phase IV clinical study to evaluate the safety and efficacy of amino acid (15) peritoneal dialysis solution in patients undergoing peritoneal dialysis with malnutrition in CAPD patients undergoing peritoneal dialysis maintenance.
Details
| Lead sponsor | Chengdu Qingshan Likang Pharmaceutical Co., Ltd |
|---|---|
| Phase | PHASE4 |
| Status | RECRUITING |
| Enrolment | 400 |
| Start date | Fri Aug 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Jun 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- End Stage Renal Disease (ESRD)
Interventions
- amino acid (15) peritoneal dialysis solution
- glucose peritoneal dialysis solution
Countries
China